Peptides
LC526 Lipo-C (FAT BLASTER)
Also called Lipo-C FAT BLASTER · LC526
Lipo-C Fat Blaster is a nutrient blend marketed for energy and extra fat loss. Its weight-loss benefit is unproven. LC526 is one formula; other Lipo-C products can contain different ingredients and strengths.
Dosage & duration
Product-specific seller example; Lipo-C formulas are not interchangeable.
GH Fat-Blaster · declared 526 mg/mL
Published example · product-specific- Dose
- 1 mL per injection
- How often
- Once weekly, into muscle
- How long
- Not stated by the seller
Research-seller description, not prescribing instructions. Its formula nominally matches LC526; different sellers’ vials are not verified equivalents.
Sources: 6
No course length is inferred from vial size.
Compare the labels
Same Lipo-C name, different formulas
LC526 adds B6, B12, inositol and NADH to a carnitine-based blend. Compare the ingredients before comparing the volume.
Scroll sideways to see both formulas.
| Ingredient | LC526 Fat Blaster | Empower Lipo-C |
|---|---|---|
| Carnitine | 300 mg (L-carnitine) | 50 mg |
| Methionine | 25 mg | 15 mg |
| Choline | 50 mg; form not specified | 50 mg choline chloride |
| Inositol | 50 mg | Not listed |
| Vitamin B12 | 1 mg | Not listed |
| Vitamin B6 | 50 mg | Not listed |
| NADH | 50 mg | Not listed |
| Dexpanthenol (B5) | Not listed | 5 mg |
Does Fat Blaster actually help with weight loss?
Its weight-loss benefit is unproven. The appeal is a shot that promises to help the body use fat for fuel, often alongside a diet or a GLP-1 medicine. But there is no dependable amount of extra weight loss to promise from LC526, or a proven timeline for seeing it.
Some ingredients have roles in normal metabolism. Carnitine, for example, helps transport fatty acids inside cells. Oral carnitine trials have produced mixed weight-loss findings; they do not test this seven-ingredient injection. Losing weight while also changing food intake, training or a GLP-1 dose cannot tell you how much the blend contributed.
What about energy and tiredness?
Energy is a separate reason people try Lipo-C. In public discussions, some people describe using it for tiredness while taking tirzepatide. Those reports explain the interest, but an energy boost is not a measure of fat loss.
B12 deficiency can cause fatigue, and correcting a deficiency is a useful clinical goal. Extra B12 has not shown a reliable performance benefit when B12 status is already adequate. Persistent fatigue deserves attention to its cause rather than assuming more ingredients or a higher dose will solve it.
How is it different from semaglutide or tirzepatide?
Semaglutide and tirzepatide act on hormone receptors involved in appetite and food intake. Their weight-management products have randomized trials measuring weight change. LC526 is a mixture of nutrients and related substances; the LC526 example in the comparison table lists neither medicine.
That makes Lipo-C neither a dose-equivalent replacement nor a proven way to make a GLP-1 work better. If the main goal is appetite control, do not expect a B-vitamin blend to reproduce a GLP-1 medicine’s effect. If the main concern is low energy during treatment, discuss that symptom and the actual ingredient panel with the prescriber.
What is in LC526, and is all Lipo-C the same?
The LC526 example in the comparison table lists L-carnitine, methionine, inositol, choline, B6, B12 and NADH. Methionine, inositol and choline are often abbreviated MIC. The NADH ingredient is the reduced form of NAD; it should not silently be relabeled NAD+.
Lipo-C is a product-family name, not one fixed recipe. Empower’s four-ingredient version has different amounts, includes dexpanthenol (B5), and does not list B6, B12, inositol or NADH. More ingredients and a larger total mass do not establish better results.
What do 526 mg/mL, a 10 mL vial and syringe units mean?
In this example, 526 mg/mL is the combined mass of the seven listed ingredients in each mL. A 10 mL container at that concentration therefore holds 5,260 mg combined. It is not 526 mg of one drug, and neither figure selects an injection amount.
On a U-100 insulin syringe, the 10-unit line represents 0.1 mL. It does not mean 10 mg or 10 IU of Lipo-C. The amount of each ingredient depends on its own mg/mL value. Changing to a different Lipo-C formula can change those ingredient amounts even when the volume stays the same.
What should I check before adding another injection?
Compare the exact formula with anything else you take, particularly other B-vitamin products. Excessive sustained B6 supplementation can damage sensory nerves; an oral supplement limit is not a validated injection limit. The LC526 example lists 50 mg of B6 per mL, so it should not be treated as an insignificant extra ingredient.
Product quality, preparation and storage also matter. If a product has been prescribed and dispensed by a pharmacy, follow that product’s instructions rather than a generic peptide-mixing routine. A research-seller listing is not a prescription or a preparation guide for human use. This blend has no single blood-level curve or established standard dose: each component would need its own information.
Why isn’t there a plot?
This informational entry has no supported pharmacokinetic model.
Common questions
How quickly should I expect results from Fat Blaster?
There is no established LC526 weight-loss timeline or reliable amount of weight loss to expect. A reported change in energy is a different outcome and does not show that the blend is burning extra body fat.
Does Lipo-C help tirzepatide or semaglutide work better?
Some people add it hoping for more energy or faster weight loss, but an added weight-loss benefit from LC526 has not been established. Review persistent tiredness and the exact product with the prescriber rather than assuming a second injection is needed.
How many units of Lipo-C should I use?
There is no universal number. “Units” on a U-100 syringe describe volume, while the amount of each ingredient depends on the formula’s concentration. The 526 mg/mL total does not specify a dose. For a prescribed, pharmacy-dispensed product, use its prescription and dispensing instructions rather than someone else’s syringe number.
Does a 10 mL Fat Blaster vial need reconstitution?
The named LC526 listings describe a 10 mL product at 526 mg/mL, rather than giving a powder-reconstitution recipe. That research listing does not establish preparation instructions for human use. For a prescribed, pharmacy-dispensed medicine, follow the instructions for its actual form; do not add water merely because other products arrive as powder.
Is NADH in Fat Blaster the same as NAD+?
The example lists NADH. NADH and NAD+ are related but distinct forms, so a label or study for one should not be substituted for the other.
Sources Labels, studies and notes behind this guide
Catalog evidence: Product or community reports. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-07. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Why people try it
- Often discussed as an add-on when dieting or GLP-1 treatment leaves someone feeling tired. That is a reported goal, not an established benefit.
- Formulas vary
- Lipo-C products do not all contain the same ingredients or concentrations.
- What it contains
- This nutrient formula contains no semaglutide or tirzepatide and is not a proven appetite-control substitute.
- 1. Twinz — Fat Blaster ingredient panel
Opened 7 Oct 2026: explicitly lists the same seven amounts per mL. Documents energy/fat-metabolism marketing and research-use-only product positioning; does not establish human efficacy, quality or a regimen.
- 2. NIH ODS — carnitine and weight loss
Mixed findings from supplemental carnitine studies in specific populations. This ingredient evidence does not establish the effect of injected LC526 or benefit alongside a GLP-1.
- 3. Villani et al. — oral carnitine plus exercise trial
Original eight-week oral trial in moderately obese women: no significant difference in body mass or fat mass. A route- and population-specific example, not proof that every carnitine trial is negative.
- 4. Wegovy — current prescribing information
Current label opened: GLP-1 receptor agonist with appetite/calorie-intake effects and randomized weight-management trials. Product-specific clinical evidence; not evidence about an LC526 add-on.
- 5. Zepbound — current prescribing information
Current label sections 12 and 14: tirzepatide acts at GIP/GLP-1 receptors, reduces calorie intake and was tested in randomized weight-management trials. Does not validate combination with LC526.
- 6. GH Peptideos Fat-Blaster product declaration and protocol
Page describes research-oriented information. Only its declared formula and published schedule are reported; its rapid-fat-loss, safety, stimulation and COA claims are not adopted.
- 7. Health-tides — LC526 / FAT BLASTER formula
Opened 7 Oct 2026: seven listed ingredient masses and 10 mL × 526 mg/mL specification. Individual per-mL amounts follow that total. Formula declaration only; not proof of a vial’s contents or clinical benefit.
- 8. Empower Pharmacy — Lipo-C product strength
Opened 7 Oct 2026: methionine/choline chloride/carnitine/dexpanthenol at 15/50/50/5 mg/mL, 10 or 30 mL vials. Used for declared formula and marketing context; efficacy and regimen claims were not adopted.
- 9. LC526 product declarations — Health-tides
Source for an advertised formula example only. A seller’s declaration does not verify a particular vial or establish dose, safety, effectiveness or a combined PK model.
- 10. NIH ODS — B12, deficiency and energy claims
Deficiency can cause fatigue; supplementation has no established performance/endurance benefit in people with adequate B12. Does not prove LC526 treats fatigue or select an injectable formulation.
- 11. NIH ODS — vitamin B6 safety
Excessive sustained supplemental B6 can cause sensory neuropathy. The evidence and dietary upper limits do not establish an injected LC526 safety threshold; no oral limit is converted into an injection dose.
- 12. FDA — milligrams, milliliters and U-100 measurement errors
FDA’s semaglutide alert supplies U-100 volume examples and explains concentration/unit errors. Applied here only to the general syringe-volume distinction, not as an LC526 safety or dose study.
- 13. FDA — compounded-drug quality and approval
General context: compounded medicines are not FDA approved and poor preparation can cause contamination or strength errors. Does not establish that a research seller is a licensed pharmacy.
Keep reading
Related compounds and examples
Related compounds
LC120 Lipo-C
LC120 is a four-ingredient “lipotropic” shot marketed for weight-management support. Its name is not a standard recipe: listings disagree about whether the ingredient amounts refer to 1 mL or the whole 10 mL vial. That difference matters before comparing doses.
LC216 Lipo-B
LC216, also called Lipo-B or Lipo-C with B12, combines carnitine, arginine, methionine, inositol and choline (MIC) and B vitamins. One published product report specifies 216 mg of listed ingredients per 10 mL serving—not per mL.
LC425 Lipo-C (FOCUS)
LC425 FOCUS is marketed for energy, mental sharpness and weight-management support. It adds ATP and an ingredient called “Eria Jarensis” to a carnitine/MIC base. That makes it different from a plain vitamin shot, but the name does not prove better focus or fat loss.